Leo Creative

  • Home
  • About
  • Our Approach
  • Our Work
    • Branding
    • Healthcare
  • Contact

Launching a new treatment for Dupuytren’s contracture

Client: Janssen Australia

dupuytens

Leo Creative worked with Janssen on the Australian launch of collagenase – a non-surgical TGA approved treatment for Dupuytren’s contracture. Like most pharma branding, the creative was done overseas, so the task was to adapt global brand assets for the local Australia market.

A wide range of collateral was produced including mandatory items like product information and consumer medicine information, printed detail aid and e-detailer (Veeva iRep), physician and patient guides.

Filed Under: work

Barker College Prospectus

Client: Barker College When Leo Creative was asked to create a new enrolment prospectus, we knew photography would be critical in communicating school life. We teamed up with Barker’s … MORE

Barker Year in Review

Client: Barker College Leo Creative has worked with Barker College for a number of years. The school has its own in-house communications team who design, write and produce a large number of … MORE

What we believe about pharma branding

Over the last decade, the pharmaceutical industry has seen significant change. There are many views on the role of branding. We have heard champions of ‘customer centric’ sales models pronounce the … MORE

Veeva iRep v Next Interact

After delivering our first project targeting Veeva’s iRep platform, here are some initial thoughts on creating content for these two widely used apps. In many ways comparing Next Interact with Veeva … MORE

Copyright © 2025 Leo Creative Pty Ltd · Genesis Framework by StudioPress · Log in